DAWN.COM

Today's Paper | March 18, 2026

Published 27 May, 2021 12:22pm

German researchers tie cold viruses used to deliver Covid-19 vaccine to rare blood clot risk

German researchers said that based on laboratory research, they believed they have found the cause of the rare but serious blood clotting events among some people who received Covid-19 vaccines made by AstraZeneca Plc and Johnson & Johnson.

The researchers, in a study not yet reviewed by experts, said Covid-19 vaccines that employ adenovirus vectors — cold viruses used to deliver vaccine material — send some of their payload into the nucleus of cells, where some of the instructions for making coronavirus proteins can be misread.

The resulting proteins could potentially trigger blood clot disorders in a small number of recipients, they suggest.

Read more from Reuters here.

Read Comments

Rain, thunderstorm expected in Karachi, other parts of Sindh from March 18-19: Met Office Next Story